The vitamin-like substance transports long-chain fatty acids into the mitochondria - also known as the "power plants of the body cells"
Authors' contributions J.T.: collected clinical data, wrote particular parts of the paper, performed the reference search K.M.: histological evaluation, wrote the histology part G.N.: performed all MRI's, included the figures, wrote the MRI findings J.L.: responsible for the irradiation of the patient, contribute in the follow-up of the patient and in the revision of the manuscript J.V.: contributed in data collection, revision and translation of the manuscript, performed surgery Authors original submitted files for images Below are the links to the authors original submitted files for images
Consulting healthcare experts to understand their risks and benefits is important
The 2019 European Society of Cardiology (ESC) and European Association for the Study of Diabetes (EASD) guidelines [11] recommend GLP-1 receptor agonists as one of the preferred monotherapy options for T2DM patients with atherosclerotic cardiovascular disease (ASCVD) or high/very high cardiovascular risk factors
But these early reports are promising and might pave the way for more research on GLP-1s in pouchees, which might ultimately lead to pouchees having access to GLP-1 drugs to help with routine pouch management